SIM
ANAC

Strategic Investment Management’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Strategic Investment Management’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-10,194
Closed -$203K – 131
2014
Q1 		$203K Buy
+10,194
New +$198K 0.03% 50

Other funds holding ANAC

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return

Strategic Investment Management's ANAC Position: Q2 2014 in Review

Strategic Investment Management sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2014, closing a stake of 10,194 shares — an estimated $203K sold.

Strategic Investment Management first reported a position in ANAC in Q1 2014 and held it in 1 quarter. The position peaked at $203K in Q1 2014. 107 funds tracked by Wall St. Rank hold ANAC as of Q2 2014.

  • Strategic Investment Management reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2014 after selling out during the quarter.
  • Strategic Investment Management sold 10,194 ANACOR PHARMACEUTICALS INC COM shares in Q2 2014, an estimated $203K.
  • Strategic Investment Management first reported a position in ANACOR PHARMACEUTICALS INC COM in Q1 2014 and held it in 1 quarter.
  • Strategic Investment Management's ANACOR PHARMACEUTICALS INC COM position peaked at $203K in Q1 2014.
  • 107 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2014.

Based on Strategic Investment Management's 13F filing for Q2 2014, filed 13 Aug 2014.